Open-Label of SPN-820 in Adults With Major Depressive Disorder
Clinical trial NCT06235905 · COMPLETED
Trial details
- NCT number
- NCT06235905
- Sponsor
- Navitor Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-15
- Primary completion
- 2024-08-18
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.